Comparing different electrical stimulation methods for treating overactive bladder in women
The Effectiveness of Parassacral Transcutaneous Stimulation Compared to Tibial Transcutaneous Stimulation, Home Protocol and Behavioral Therapy in the Treatment of Female Hyperative Bladder: Randomized Clinical Trial
NA · Centro de Atenção ao Assoalho Pélvico · NCT04909047
This study is testing different electrical stimulation methods to see which one helps women with overactive bladder feel better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Centro de Atenção ao Assoalho Pélvico (other) |
| Locations | 3 sites (Salvador, Bahia and 2 other locations) |
| Trial ID | NCT04909047 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of parassacral transcutaneous stimulation compared to tibial transcutaneous stimulation and a home protocol for treating female overactive bladder. Women aged 18 to 65 with symptoms of overactive bladder will be randomized into three groups to assess the efficacy of these interventions. The study aims to provide insights into which method may offer better relief from urinary urgency symptoms. By comparing these approaches, the trial seeks to enhance treatment options for women suffering from this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 to 65 who experience symptoms of overactive bladder.
Not a fit: Patients with cognitive deficits, psychiatric illnesses, or those with specific medical conditions such as chronic renal failure or pregnancy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide women with more effective treatment options for managing overactive bladder symptoms.
How similar studies have performed: While there are studies on the effectiveness of these stimulation methods individually, this trial aims to compare them directly, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with symptoms of overactive bladder, aged 18 to 65 years. Exclusion Criteria: * Participants who have difficulty understanding the stages of the research, report cognitive deficit or psychiatric illness, patients with congenital orthopedic / neurological diseases, overactive bladder due to neurological impairment, presence of lower urinary tract infection, sensory deficit in the sacral or tibial region, diagnosis of chronic renal failure, patients with pacemakers and implantable cardioverter defibrillators and pregnant women.
Where this trial is running
Salvador, Bahia and 2 other locations
- Cebtro de Atebçao ao Assolaho Pévico- Escola Bahiana de Medicina e Saúde Pública — Salvador, Bahia, Brazil (RECRUITING)
- Centro de Atenção ao assoalho pélvico — Salvador, Bahia, Brazil (RECRUITING)
- Centro de Atenção ao Assoalho Pelvico — Salvador, Ba, Brazil (RECRUITING)
Study contacts
- Study coordinator: Patrícia Lordelo, PhD
- Email: pvslordelo@hotmail.com
- Phone: +5571988592400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Transcutaneous Electrical Nerve Stimulation, Urgent Urinary Incontinence, Bladder Hyperactive, Women